In Malaysia, it’s not unusual to find health supplements being sold online without proper approval. The NPRA has even flagged cases where products made bold “100% safe” claims but turned out to be unregistered. To avoid this risk, every health supplement must first go through the NPRA registration process.
In the next section, we’ll look at what counts as a supplement in Malaysia, NPRA Regulations for Health Supplements, the steps for registration, and the rules on what you can claim.
Health Supplements in Malaysia
A health supplement is any product used to supplement a diet and to maintain, enhance, and improve the health function of the human body. It is presented in small unit dosage forms (to be administered), such as capsules, tablets, powder, and liquids, and shall not include any sterile preparations (i.e., injectables, eyedrops). Vitamin and mineral supplements for pregnant and lactating women are also considered health supplements. They are taken orally only.
Health supplements may contain one or more of the following:
- Vitamins, minerals, amino acids, fatty acids, enzymes, probiotics, and other bioactive substances
- Substances derived from natural sources, including animal, mineral, and botanical materials in the forms of extracts, isolates, concentrates, and metabolites
- Synthetic sources of ingredients mentioned above, but only where safety has been proven
Products that are meant to be eaten as a meal, injectables and sterile preparations, and products that contain cells, tissues, organs, or any substance derived from the human body are not considered health supplements and are subject to different regulations. Products that contain substances listed in the Schedule of the Poison Act are also not regulated as health supplements. Products intended to be taken by any other route are not considered health supplements.
Preparations that are made by a healthcare practitioner to be given directly to their patients as part of treatment are exempted from registration as health supplements.
Recent NPRA Updates for Health Supplements
Here are the latest health supplement updates in Malaysia 2026:
July 2026 – Updated DRGD
NPRA issued the Drug Registration Guidance Document (DRGD), Third Edition, 12th Revision, July 2026, including the updated requirements applicable to health supplements under Appendix 6. Applicants should use the current DRGD when preparing new registration applications and post-registration submissions.
June 2026 – Vitamin B6 Warning
NPRA issued a directive requiring an additional warning statement for applicable health supplements and OTC products containing Vitamin B6, addressing the risk of peripheral neuropathy. Applicants and Product Registration Holders should follow the directive for the applicable product information and labeling requirements.
April 2026 – Animal-Derived Materials
The regulatory authority also issued an update concerning analytical testing and labeling declarations for health supplements containing animal-derived materials. Products using such materials should be assessed against the applicable NPRA requirements before submission.
Health Supplements: Adult Maximum Daily Levels of Vitamins and Minerals Allowed by NPRA Malaysia
Let’s look into the maximum daily levels NPRA has provided under the DRGD, Appendix 6:
| Vitamins & Minerals | Daily Level (Upper Limit) |
| Vitamin A | 5000 IU |
| Vitamin D | 1000 IU |
| Vitamin E | 800 IU |
| Vitamin K (K1 and K2)* | 0.12 mg |
| Vitamin B1 & B6 | 100 mg |
| Vitamin B2 | 40 mg |
| Vitamin B5 | 200 mg |
| Vitamin B12 | 0.6 mg |
| Vitamin C | 1000 mg |
| Folic Acid, Biotin | 0.9 mg |
| Nicotinic Acid, Zinc | 15 mg |
| Niacinamide | 450 mg |
| Boron | 6.4 mg |
| Calcium | 1200 mg |
| Chromium | 0.5 mg |
| Copper | 2 mg |
| Iodine | 0.3 mg |
| Iron* | 20 mg |
| Magnesium | 350 mg |
| Manganese | 3.5 mg |
| Selenium | 0.2 mg |
| Molybdenum | 0.36 mg |
| Phosphorous | 800 mg |
Notes:
- Vitamin K (K1 and K2) is restricted only for combination with other vitamins and minerals in oral preparations. Vitamin K (K1 and K2) as a single ingredient in an oral preparation is not allowed.
- As part of a multivitamin and mineral preparation, levels higher than the 20mg limit for pre- and antenatal use, established for adults, may be allowed at the authority’s discretion.
- Any form of fluoride as an ingredient is not allowed in health supplement product formulations.
Health Supplement Claims and Substantiation Requirements in Malaysia
The NPRA also regulates the health claims that can be made for health supplements. All health claims must be supported by scientific evidence. The NPRA has a list of approved health claims that can be made for certain ingredients and health supplements.
All health supplement claims must be accurate and truthful and should not mislead consumers. Claims should be supported by scientific evidence and should only promote health maintenance and promotion, not the treatment, cure, or prevention of disease. The health supplement claims should:
- Be consistent with the definition of a health supplement, which is a product that is intended to supplement the diet and maintain, enhance, or improve the health function of the human body.
- Enable consumers to make informed choices about which products to purchase.
- Support the safe, beneficial, and appropriate use of the product.
- Be supported by scientific evidence that is proportional to the type of claim being made.
- Be for health maintenance and promotion purposes only, and should not imply that the product can treat, cure, or prevent disease.
- Not be medicinal or therapeutic in nature, implying to be a cure, treatment, or prevention of diseases.
Health supplement claims can be divided into three categories:
1. Health Supplements with General or Nutritional Claims (Low Risk)
These health supplements are primarily intended to maintain general health and provide benefits that go beyond what can be achieved through normal dietary intake. These types of supplements can support healthy growth and development, nourish the body, relieve general tiredness and weakness, and help to maintain good health. They can also include claims for energy, vitality, and strengthening the body.
For a health supplement making a General or Functional Claim relating to vitamins and/or minerals, the product must contain at least 15% of the applicable Codex Nutrient Reference Value (NRV) per daily dose. Other ingredients must be supported by appropriate evidence. Where the vitamin or mineral content is below 15% NRV, the specific claim is not permitted unless supporting evidence demonstrates the claimed effect at the lower level.
These claims should be in line with the established nutritional knowledge in reference texts. They must be related to general well-being aligned with scientific knowledge. The claim should not refer to the structure and/or human body function.
Evidence to substantiate these claims includes standard references or recommendations from regulatory authorities or reference organizations.
2. Health Supplements with Functional Claims (Medium Risk)
Health supplements that are used to maintain or improve the structure or function of the body but do not make disease-related claims are classified as functional supplements. These claims must be based on a single ingredient.
Functional claims on established nutrients and ingredients like vitamins and minerals with daily recommended values should meet the conditions for nutrient function claims as set by the regulatory authority. The claims should have a sceintific support that’s consistent according to the scientific review and evaluation. They should also be in accordance with Malysian HS principles.
Substantiating these claims require one or more of the following evidence:
- Standard references
- Usage recommendations from regulatory authorities or reference organizations
- Good quality scientific evidence from human observational studies
- Peer-reviewed scientific data or meta-analysis
Only when the human experimental study is not ethical will animal studies and epidemiological studies or other scientific literature and documented traditional use be accepted.
3. Health Supplements with Claims to Reduce the Disease Risk (High Risk)
Such supplements claim to reduce the risk of disease or health-related conditions significantly. The claim wording might say that it helps to reduce osteoporosis risk by strengthening bones or any other condition.
Strong and consistent scientific evidence needs to back the relationship between the HS ingredient or product. Documents in authoritative reference texts or those references that regulatory authorities or international organizations recognize and that adhere to the crucial principles of HS claims are the criteria.
Compulsory evidence for such claims is scientific evidence from a human intervention study on the ingredient and/or product. Toxicological study (chronic) and pharmacological study are also needed.
A minimum of one additional piece of evidence can come from standard references, usage recommendations from regulatory authorities and reference organizations, published scientific reviews, meta-analyses, or reports prepared by expert committees or their opinions, depending on approval from authorities.
Illustrative Substantiative Evidence for the Health Claims
The level of scientific evidence required to support each type of claim varies. General or nutritional claims require the least evidence, while disease risk reduction claims require the most.
Manufacturers of health supplements can use evidence from books, pharmacopoeias, scientific reviews, and other sources to support their claims in their product dossier. However, all references must be current as of the date of submission. The National Pharmaceutical Regulatory Agency (NPRA) also publishes a list of acceptable reference texts, organizations, and regulatory authorities.
| Reference Texts | Organizations |
Reference Regulatory Authorities
|
|
|
|
Notes:
- This list is not meant to be exhaustive. It will be reviewed from time to time.
- The Authority will conduct a detailed evaluation of the evidence included in the report. It’s done to ensure that the health claim is substantiated.
- The Authority will consider reviews other than those listed above if the standards of evidence are consistent with those of the Authority.
Specific Dossier Requirements for Health Supplements in Malaysia
NPRA’s Appendix 6: Guideline on Registration of Health Supplements sets out specific dossier requirements for health supplements. These requirements should be read together with the main Drug Registration Guidance Document (DRGD), which contains the common requirements for preparing a product registration dossier. The information required may vary according to the product, ingredients, claims, dosage form, manufacturing arrangements, and applicable evaluation route.
The current Appendix 6 organizes the specific dossier requirements as follows:
1. Product Validation
The product validation section covers the fundamental particulars used to identify and assess health supplements. These include the following:
Product Name
The proposed product name may include the brand name, dosage form, and strength. NPRA requires the dosage form and strength to form part of the product name where applicable, allowing different dosage forms or strengths of a product to be distinguished.
For products containing more than one active ingredient, the strength of the individual active ingredients should not be incorporated into the product name. NPRA may also require a product name to be changed if it is considered similar to an existing registered product. Names that may mislead consumers, imply disease treatment, indicate superiority, create ambiguity about the nature of the product, or resemble names of adulterated products are subject to restrictions.
The current Appendix 6 provides a detailed list of non-permissible product-name categories. It includes specific disease names, superlative expressions, ambiguous names, names suggesting professional endorsement, names implying claims, and names referring to organs or the brain. The list is not exhaustive. NPRA reserves the right to disallow other names it considers misleading, improper, or not factual.
Dosage Form
The dosage form of the product must be specified as part of the product information. The supporting documentation should be consistent with the proposed dosage form and the information provided elsewhere in the registration dossier.
Active Ingredients
Information on each active ingredient should include its name, strength, source, and relevant remarks. The quantity of an ingredient should be expressed appropriately according to the dosage form, such as quantity per unit dose, percentage composition, weight per milliliter, or quantity per measured dose. Metric units should be used. For ingredients derived from natural sources, the species name should also be declared where applicable.
The source of an active ingredient should be identified, such as animal, plant, synthetic, or another applicable source. Where an ingredient provides an equivalent active component—for example, a raw material that provides a specified amount of a vitamin—the equivalent amount should also be stated.
Protected or Endangered Ingredients
If the formulation contains ingredients derived from protected or endangered wildlife or botanical species, the applicant has to comply with the Malaysian legislation that applies and obtain the necessary permits or licenses.
NPRA specifically refers to the Wildlife Conservation Act 2010 (Act 716) and the International Trade in Endangered Species Act 2008 (Act 686) for related wildlife-derived ingredients. Where applicable, copies of permits or licenses must be submitted with the product registration application.
New Health Supplement Active Ingredients
Additional information is required where a product contains a new health supplement active ingredient. The documentation should support the safe use and proposed dose of the new active ingredient as a health supplement. Clinical studies or scientific evidence are identified as mandatory for high claims.
2. Animal-Origin Materials
Any ingredient derived from an animal source must be declared, and the type of animal must be specified. This information is relevant both to the formulation of information and to the supporting documentation submitted as part of the dossier.
3. Manufacturer and Manufacturing-Related Information
The dossier must provide the relevant manufacturer with information and demonstrate compliance with the applicable GMP requirements. It also addresses contract manufacturers, repackers, second sources, other manufacturers involved in the manufacturing process, and imported products.
4. Administrative Data and Product Information
The dossier should provide detailed product information, including the following:
- Product description
- Indication or usage
- Recommended dose and use instructions
- Route of administration
- Contraindications
- Warnings and precautions
- Drug interactions
- Pregnancy and lactation information
- Side effects or adverse reactions
- Signs and symptoms of overdose and treatment
- Storage conditions
- Shelf life
- Therapeutic code, where applicable
These particulars should be consistent with the information provided elsewhere in the registration dossier and, where applicable, the proposed product label.
5. Batch Manufacturing Formula
The BMF should state the batch size and the actual master manufacturing formula. It should identify each active ingredient and excipient, its function, quantity per unit dose, and batch quantity and applicable overages. NPRA requires the BMF documentation to be attached and verified by authorized personnel.
An important point is that the current Appendix 6 states that a change in formulation of an active ingredient or excipient is not allowed during product evaluation.
6. Packaging Information
For tablets, pills and capsules, the maximum pack size is based on a quantity not exceeding six months’ usage, subject to the exceptions and justifications specified by NPRA. For products carrying disease-risk-reduction claims, the maximum pack size is one month’s supply, unless justified. Certain soft-gel dosage forms with a tail or twist-and-squeeze design must have a child-proof cap.
Packaging information includes details such as pack size and fill, container type and, where applicable, barcode or serial number, and recommended pricing information.
7. Labelling Documentation
NPRA requires applicants to provide the applicable product label or mock-up and directs applicants to the relevant general and specific labeling appendices of the DRGD.
Additional requirements apply to certain products. Products containing animal-derived substances require an appropriate declaration, while products containing porcine material require a specific declaration identifying the animal origin. For health supplements making disease-risk-reduction claims, NPRA also provides for Consumer Medication Information Leaflet (RiMUP) requirements.
8. Product Owner, Importer and Contract Manufacturer Documentation
The dossier must identify the relevant parties involved in the product, including the product owner, product holder, manufacturer, repacker, other manufacturers involved in manufacturing, importer where applicable, and store address.
Depending on the arrangement, supporting documents can include the following:
- Letter of authorization from the product owner
- Letter of appointment of a contract manufacturer and/or repacker
- Letter of acceptance from the contract manufacturer and/or repacker
- Certificate of Pharmaceutical Product (CPP)
- Certificate of Free Sale (CFS)
- GMP documentation
The applicable document depends on the product’s regulatory and manufacturing circumstances.
9. Manufacturing Process and In-Process Quality Control
The in-process quality-control information should identify the tests performed, the manufacturing stage at which they are conducted, testing frequency, sample quantity, specifications, and test methods.
10. Finished Product Quality Control
It should provide the applicable release and shelf-life specifications, including the tests, acceptance limits, and test methods. The Certificate of Analysis (CoA) for the finished product must contain the product specifications and analytical results, and the tests and specifications should correspond with the finished-product specification document.
For new health supplement registrations with general claims, Appendix 6 specifies submission of two batches of finished-product CoAs. For products containing ingredients from natural sources, NPRA specifies finished-product testing for heavy metals, including limits for lead, arsenic, mercury, and cadmium. Other quality-control requirements apply according to dosage form and product characteristics.
11. Stability Data
Stability information must support the proposed storage conditions and shelf life of the product.
12. Active-Ingredient Specifications and Certificate of Analysis
The drug-substance section requires a Certificate of Analysis for each active ingredient (raw material) before registration. The certificate must include the relevant specifications and analytical results.
13. Dossier Requirements Based on the Claim Category
According to the current Appendix 6:
- General/Nutritional Claims and Functional Claims (medium) follow the abridged evaluation route.
- Disease Risk Reduction Claims (high) follow the full evaluation route.
GMP Requirements for Health Supplements in Malaysia
Health supplement manufacturers must comply with the applicable Good Manufacturing Practice (GMP) requirements recognized by NPRA. For imported products, the GMP documentation required depends on the product and manufacturing arrangements.
For products making general or functional claims, there are specific routes for demonstrating GMP compliance. These may include compliance with Malaysian GMP requirements, an acceptable GMP standard in the country of origin, or, where applicable, GMP certification from an independent body recognized by NPRA. The relevant GMP evidence should be submitted as part of the registration documentation.
Where contract manufacturing or repacking is involved, the applicant must also provide the applicable documentation identifying the manufacturing arrangement and parties involved. Applicants should ensure that the GMP status and manufacturing information submitted to NPRA remain consistent with the actual manufacturing site and product.
Labelling and Packaging Requirements for Health Supplements in Malaysia
Health supplement labels and packaging must comply with the applicable NPRA requirements and be consistent with the information submitted in the product registration dossier. Specific requirements are regarding packaging, product labels, standard labeling, prohibited visuals or graphics, and package inserts. Applicants should also refer to the relevant general labeling requirements in the DRGD.
Particular requirements may apply to products containing animal-derived ingredients, certain dosage forms, or products making specific types of claims. For example, appropriate declarations are required for certain animal-derived materials. NPRA also restricts certain product names, statements, and visual elements that may mislead consumers or imply inappropriate therapeutic or other claims.
For products making disease-risk-reduction claims, additional consumer information requirements may apply.
Recent NPRA Updates Affecting Health Supplement Labelling in Malaysia
NPRA has issued several updates affecting health supplements during 2026. The Drug Registration Guidance Document (DRGD) was updated to its Third Edition, 12th revision, in July 2026. NPRA also issued a June 2026 directive requiring an additional warning statement for health supplements and OTC products containing Vitamin B6 in relation to the risk of peripheral neuropathy.
The Vitamin B6 directive applies to health supplements and OTC products containing Vitamin B6 above 10 mg and requires the specified warning statement on the label, package insert, and Consumer Medication Information Leaflet (RiMUP).
Health Supplements Registration Process in Malaysia
Applications for new health supplement registration are submitted through the QUEST3+ system. The process involves the following steps:
Step 1: Pre-Submission & Preparation
The preparation stage through the Quest 3+ system includes the following:
- Obtaining the required QUEST3+ token/digital certificate for conducting transactions through the system.
- Determining the appropriate product classification. Applicants who are unsure whether their product falls within the health supplement category may apply for product classification before registration.
- Selecting the applicable payment method.
- Preparing the key documents required for the health supplement application, including the applicable GMP documentation and supporting product information.
- Preparing the registration dossier according to the applicable NPRA requirements and relevant guidelines.
Applicants should ensure that the appropriate product category and application form are selected before proceeding with submission.
Step 2: Submission of the Registeration Application
Once the product is ready, the applicant can submit their application online by uploading all required documents and completing all four parts of the application (I, II, III, and IV). In the QUEST System, online application forms are available for different product categories. It is important to fill out the correct application by selecting the appropriate section from the display panel.
Step 3: Regulatory Outcome
The National Pharmaceutical Regulatory Agency (NPRA) will then review the application and make a decision about whether to approve or reject the product for registration. This decision is based on the outcome of the evaluation of the samples and documents submitted.
The decision of the authority will be sent to the product registration holder via an official letter/e-mail. The NPRA may also request additional information from the manufacturer during the review process. The Authority may reject, cancel, or suspend the registration where there are deficiencies relating to the product’s safety, quality, or efficacy, or where applicable, registration conditions have not been fulfilled.
Step 4: Post-registration Process
Once the health supplement is registered, the Product Registration Holder remains responsible for maintaining the product’s quality, safety, and efficacy and fulfilling the conditions and commitments imposed as part of registration.
The registration is generally valid for five years, or for the period specified in the Authority’s database, unless it is suspended or cancelled. An application for re-registration should be submitted within six months before the registration expires.
Post-Registration Requirements for Health Supplements in Malaysia
Apart from the things mentioned in Step 4, health supplement registration holders should take care of the following:
Variations and Other Post-Registration Changes
Changes to a registered product or its registered particulars should be handled through the applicable NPRA post-registration or variation procedure. The appropriate route depends on the nature of the proposed change.
Pharmacovigilance and Post-Market Obligations
NPRA maintains separate pharmacovigilance guidance for Product Registration Holders, which should be consulted alongside the relevant product registration requirements.
Product Quality and Recall
Post-registration compliance can also involve product-quality monitoring and recall procedures where required. NPRA’s current DRGD includes a dedicated Appendix 34: Guideline for Product Quality Reporting and Recall Procedures, updated in July 2026. Accordingly, Product Registration Holders should maintain appropriate systems for monitoring the registered product and responding to quality, safety, or regulatory concerns throughout its lifecycle.
NPRA Safety Alert: Turmeric and Curcuminoids Linked to Potential Liver Injury
On October 6, 2026, Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) issued a safety alert highlighting the potential risk of liver injury associated with oral health supplements and natural products containing turmeric (Curcuma spp.) or curcuminoids, including curcumin.
Safety Concern and Available Evidence
The alert follows safety reviews by international regulators, including Health Canada and Australia’s Therapeutic Goods Administration (TGA), which identified a possible association between oral turmeric- or curcuminoid-containing products and hepatotoxicity. These reactions appear to be unpredictable and are not consistently related to the dose or duration of use. Products formulated to enhance absorption, including those containing piperine, may present an increased risk. People with existing or previous liver conditions may also be more susceptible.
As reported in the alert, the NPRA had received 32 adverse drug reaction reports involving 71 suspected adverse events associated with Curcuma spp. or curcuminoids. No reports specifically identified hepatotoxicity. However, several liver-related events had been reported.
Advice for Supplement Companies and Healthcare Professionals
The NPRA advises healthcare professionals to ask patients about supplement use. They must:
- Counsel people with existing or previous liver conditions to avoid oral products that have turmeric or curcuminoids.
- Report adverse events that are suspected
Consumers who experience symptoms like the following should discontinue use. They may also receive medical attention if needed:
- Continuous nausea or vomiting
- Unusual fatigue
- Itching
- Yellowing of the skin or eyes
- Dark urine
- Upper-right abdominal pain
- Appetite loss
The alert is about oral supplements and natural products having turmeric or curcuminoids. It does not concern turmeric used as a culinary spice in small dietary amounts. Supplement companies should review the alert. They should assess whether their product safety information and risk communications need attention.
Conclusion
The NPRA’s regulation of health supplements is designed to protect consumers from unsafe and ineffective products. By requiring manufacturers to register their products and provide evidence of safety and efficacy, the NPRA helps to ensure that only high-quality health supplements are available to Malaysian consumers.
If you are a manufacturer or importer of health supplements and need assistance with product registration or enterprise compliance in Malaysia, contact Artixio for end-to-end regulatory support. We have a team of experienced regulatory experts who can help you to navigate the complex NPRA registration process and ensure that your products are in compliance with all applicable regulations.
Artixio looks forward to working with you to bring your health supplements to the Malaysian market safely and efficiently. Contact us at info@artixio.com.
FAQs
Q. What is a health supplement claim?
A health supplement claim refers to the beneficial effects of consuming a health supplement in order to promote good health and well-being. It includes claims relating to nutrition, body structure/function, physiological discomfort, and reduction of health-related risks or conditions, subject to NPRA’s claim requirements and substantiation criteria.
Q. What is the QUEST 3+ System?
QUEST3+ is NPRA’s online system used for product registration, variation, licensing, renewal, and other regulatory transactions. Health supplement registration applications are submitted through the applicable QUEST3+ modules.
Q. Who is a Product Registration Holder, and what are they responsible for after the health supplement registration process in Malaysia?
For an imported health supplement, the applicable Malaysian Product Registration Holder is responsible for the registration and ongoing regulatory obligations associated with the product. The PRH must fulfill the conditions and commitments imposed during registration and maintain compliance with applicable quality, safety and efficacy requirements throughout the product’s lifecycle.
This PRH is responsible for fulfilling the conditions and commitments imposed during registration and maintaining the product’s quality, safety, and efficacy throughout the registration period. Applicable changes and post-registration requirements must also be managed in accordance with NPRA requirements.
Q. What is the fee for the registration of health supplements?
For registration of health supplements, the fee per product is RM 1000 for processing. The analysis fee for a single ingredient is RM 1200, and for two or more ingredients, it is RM 2000, making the total RM 2200 or RM 3000, respectively.


